ConductScience.org, home

Paper575122

Radiosensitization of hypoxic tumor cells by cis- and trans-dichlorodiammineplatinum (II).

Douple EB and 1 other. Int J Radiat Oncol Biol Phys, 1979. Cited by 117 papers, by iCite.

Cite this record

ConductScience Library. Radiosensitization of hypoxic tumor cells by cis- and trans-dichlorodiammineplatinum (II). Papers, record 575122. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/575122

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Radiosensitization of hypoxic tumor cells by cis- and trans-dichlorodiammineplatinum (II).
PubMed
Journal
Int J Radiat Oncol Biol Phys
PubMed
Year
1979
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
117
iCite
Relative citation ratio, by iCite
5.67
iCite
Revised in PubMed
2019-07-08
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Douple EBE B
2Richmond RCR C

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
CisplatinMajor topic
Mammary Neoplasms, ExperimentalMajor topic
OxygenMajor topic
Radiation-Sensitizing AgentsMajor topic
Animals
Dose-Response Relationship, Radiation
Female
Hypoxia
Mice
Mice, Inbred C3H
Time Factors

Source PubMed

Download CSV of topics

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 117 citations.

PMIDTitleJournalYearIn PapersSource
26495872Design and pharmacokinetical aspects for the use of inorganic nanoparticles in radiomedicine.Br J Radiol2016https://conductscience.org/library/papers/26495872PubMed
19860913Combined treatment with lexatumumab and irradiation leads to strongly increased long term tumour control under normoxic and hypoxic conditions.Radiat Oncol2009https://conductscience.org/library/papers/19860913PubMed
19461907Chemoradiotherapy for esophageal cancer.Gastrointest Cancer Res2009https://conductscience.org/library/papers/19461907PubMed
8519652Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.Br J Cancer1995https://conductscience.org/library/papers/8519652PubMed
7547255Continuous carboplatin infusion during 6 weeks' radiotherapy in locally inoperable non-small-cell lung cancer: a phase I and pharmacokinetic study.Br J Cancer1995https://conductscience.org/library/papers/7547255PubMed
6932930An appraisal of in vivo assays of excised tumours.Br J Cancer Suppl1980https://conductscience.org/library/papers/6932930PubMed
6682105Daily cis-dichlorodiammineplatinum (II) as a radio-enhancer: a preliminary toxicity report.J Cancer Res Clin Oncol1983https://conductscience.org/library/papers/6682105PubMed
6203548Interactions of radiation and adriamycin, bleomycin, mitomycin C or cis-diamminedichloroplatinum II in intestinal crypt cells.Br J Cancer1984https://conductscience.org/library/papers/6203548PubMed
3606943Response of an ocular melanoma to subconjunctival injection of 5-thio-D-glucose or cis-platin.Br J Cancer1987https://conductscience.org/library/papers/3606943PubMed
1503898The binding of cis-dichlorodiammineplatinum(II) to extracellular and intracellular compounds in relation to drug uptake and cytotoxicity in vitro.Br J Cancer1992https://conductscience.org/library/papers/1503898PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/575122

GET https://conductscience.org/api/papers/v1/575122/authors